Steven Romick - First Pacific Advisors,
Holding/activity history for Standard Biotools Inc (LAB)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2020 Q4 | 0 | 0.00 | Sell 100.00% | 0.05 | SEC | ||
| 2020 Q3 | 20,100 | 0.05 | $188.26 | $3,784,000 | SEC | ||
| 2020 Q2 | 20,100 | 0.04 | Reduce 6.07% | <0.01 | $166.12 | $3,339,000 | SEC |
| 2020 Q1 | 21,400 | 0.04 | Reduce 0.33% | <0.01 | $126.40 | $2,705,000 | SEC |
| 2019 Q4 | 21,470 | 0.03 | Reduce 2.41% | <0.01 | $169.17 | $3,632,000 | SEC |
| 2019 Q3 | 22,000 | 0.03 | $168.00 | $3,696,000 | SEC | ||
| 2019 Q2 | 22,000 | 0.03 | Reduce 10.57% | <0.01 | $172.91 | $3,804,000 | SEC |
| 2019 Q1 | 24,600 | 0.03 | Add 11.16% | <0.01 | $152.97 | $3,763,000 | SEC |
| 2018 Q4 | 22,130 | 0.03 | Add 23.08% | <0.01 | $126.34 | $2,796,000 | SEC |
| 2018 Q3 | 17,980 | 0.02 | $173.69 | $3,123,000 | SEC | ||
| 2018 Q2 | 17,980 | 0.02 | Add 6.20% | <0.01 | $179.53 | $3,228,000 | SEC |
| 2018 Q1 | 16,930 | 0.02 | Reduce 13.45% | <0.01 | $161.72 | $2,738,000 | SEC |
| 2017 Q4 | 19,560 | 0.02 | Add 18.12% | <0.01 | $159.51 | $3,120,000 | SEC |
| 2017 Q3 | 16,560 | 0.02 | Reduce 47.64% | 0.02 | $150.97 | $2,500,000 | SEC |
| 2017 Q2 | 31,630 | 0.04 | Add 91.00% | 0.02 | $154.13 | $4,875,000 | SEC |
| 2017 Q1 | 16,560 | 0.02 | Reduce 18.82% | <0.01 | $143.48 | $2,376,000 | SEC |
| 2016 Q4 | 20,400 | 0.02 | $128.38 | $2,619,000 | SEC | ||
| 2016 Q3 | 20,400 | 0.02 | $137.50 | $2,805,000 | SEC | ||
| 2016 Q2 | 20,400 | 0.02 | Reduce 59.52% | 0.04 | $130.29 | $2,658,000 | SEC |
| 2016 Q1 | 50,400 | 0.06 | $117.12 | $5,903,000 | SEC | ||
| 2015 Q4 | 50,400 | 0.06 | $123.63 | $6,231,000 | SEC | ||
| 2015 Q3 | 50,400 | 0.05 | $108.47 | $5,467,000 | SEC | ||
| 2015 Q2 | 50,400 | 0.05 | $121.21 | $6,109,000 | SEC | ||
| 2015 Q1 | 50,400 | 0.05 | $126.09 | $6,355,000 | SEC | ||
| 2014 Q4 | 50,400 | 0.04 | Reduce 49.35% | 0.04 | $107.90 | $5,438,000 | SEC |
| 2014 Q3 | 99,500 | 0.09 | Add 17.75% | 0.01 | $101.75 | $10,124,000 | SEC |
| 2014 Q2 | 84,500 | 0.07 | $102.40 | $8,653,000 | SEC | ||
| 2014 Q1 | 84,500 | 0.07 | $98.21 | $8,299,000 | SEC | ||
| 2013 Q4 | 84,500 | 0.08 | Buy | 0.08 | $91.37 | $7,721,000 | SEC |